Dr Reddy’s seeks DCGI nod to conduct phase-3 clinical trial of Russian COVID-19 vaccine Sputnik V
New Delhi: The Hyderabad-based Dr Reddy's Laboratories has applied to the Drugs Controller General of India for permission to conduct ...
Read moreNew Delhi: The Hyderabad-based Dr Reddy's Laboratories has applied to the Drugs Controller General of India for permission to conduct ...
Read moreBhubaneswar: Amid the rising number of nCoV cases, the state government has allowed sale of Favipiravir tablet and Remdesivir injectable ...
Read moreNew Delhi: Serum Institute of India (SII) said Thursday it is putting on hold clinical trials of an experimental COVID-19 ...
Read moreHyderabad: Dr Reddys Laboratories Ltd Wednesday announced the launch of Remdesivir, meant for treatment of COVID-19 patients, under a brand ...
Read moreNew Delhi: The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for ...
Read moreNew Delhi: India’s drug regulator has cancelled the rapid diagnostic kit import licenses of three firms and suspended that of ...
Read moreNew Delhi: Serum Institute of India (SII) has partnered with ‘AstraZeneca’ for manufacturing the Oxford vaccine candidate for COVID-19. Serum ...
Read moreNew Delhi: Shares of Glenmark Pharmaceuticals on Monday tumbled nearly 6 per cent after India's drug regulator sought clarification from ...
Read moreNew Delhi: As the whole world is struggling to find a vaccine to tackle the pandemic coronavirus, India has found ...
Read moreHyderabad: Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture ...
Read more